Phase 4 PROCEED Trial Shows Earlier Provenge Delays First Chemotherapy Exposure
Provenge or Sipuleucel-T (sip-T) remains not well understood by many prostate cancer survivors as well as some treating physicians. Because Provenge does not immediately control PSA or disease progression it creates a situation where some [...]
Long-term Survival of Extremely Advanced Prostate Cancer Patients Diagnosed with PSA over 500 ng/ml
It is generally believed that combination hormone therapy (ADT 2, 3 or 4) is superior to mono-therapy (with just one drug). With this in mind researchers investigated the survival of hormone-naïve prostate cancer survivors diagnosed [...]
A New Phase III Trial of ODM-201 for Men with Castrate Resistant Prostate Cancer without Visible Metastases
Bayer HealthCare and Orion Corporation (a Finnish pharmaceutical company) have announced that they have begun enrollment in a randomized Phase III clinical trial of a new investigational treatment for men with advanced prostate cancer. ODM-201 [...]
Depression In Men Receiving Androgen Deprivation Therapy (ADT)
Yesterday I wrote about the cognitive effects of hormone therapy (ADT), today’s topic is about depression in men on ADT. It is commonly known that men on ADT often experience many physical and psychological side [...]
Chemo-Brain and ADT for Advanced Prostate Cancer – Does It Exist?
When I went on my first round of hormone therapy (ADT) I experienced severe cognitive side effects. I found it impossible to concentrate, read and remember anything. I lost the ability to navigate the New [...]
Sharing My Harry Pinchot Acceptance Speech
As I shared on this blog earlier thanks to many of you I was awarded the 2014 Harry Pinchot award. This prestigious award is made annually by the Prostate Cancer Research Institute (PCRI) and is [...]